• Post-Doctoral Research Fellow/Staff Scientist, Stem Cell and T Cell Gene Therapy

    Job ID
    12134
    Type
    Regular Full-Time
    Company
    Fred Hutchinson Cancer Research Center
    Location
    US-WA-Seattle
    Category
    Staff Scientist
  • Overview

    Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.

    Responsibilities

    The Stem Cell and Gene Therapy (SCGT) program at Fred Hutch is recruiting a postdoctoral fellow or research associate to develop and manage gene editing approaches using xenograft murine models. The overall goal of the SCGT program is study hematopoietic cell biology and develop novel cell and gene therapy strategies for patients with genetic, infectious and malignant diseases. The position involves additional responsibilities, such as oversight of murine studies, processing of primary tissue samples, culture/analysis of engineered cells, and immunological assay design and readouts. The candidate will study and develop methods to deliver novel gene editing reagents using direct in vivo injection delivery systems and longitudinally track modified cells using molecular and next-generation sequencing techniques. This individual will work under the PI and in collaboration with other senior members of the research team. The candidate will be expected to publish and present their work in both internal and external events.

    Qualifications

    A PhD in molecular/cellular biology or other related scientific fields with a minimum of 3-5 years of post-doctoral research experience is required. The individual must possess knowledge of gene therapy techniques and current applications. Experience designing and performing mouse xenograft experiments including sample preparation and processing is also required. Candidates with a background in hematopoietic stem cell biology are highly desired. Experience is preferred in one or more of the following areas: hematopoietic stem cell cultures/model systems, in vivo studies, flow cytometry/flow-assisted cell sorting, and/or molecular biology techniques e.g. quantitative PCR.

     

    To be successful in this position, the candidate must be highly motivated and able to work independently to design and execute experiments, possess a high level of initiative and attention to detail, and must also be able to multi-task and prioritize work at short notice. They must also be capable of working independently in a team environment. Candidates with excellent organizational skills and communication skills (written and oral) are encouraged to apply.

    Our Commitment to Diversity

    We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We are proud to be an Equal Opportunity and VEVRAA Employer. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at escmail@fredhutch.org or by calling 206-667-4700.

    Options

    Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
    Share on your newsfeed